Value Management+research buy krebskrebs
Start price
02.10.23
/
50%
€1.62
Target price
02.10.24
€2.00
Performance (%)
-20.37%
End price
03.10.24
-
Summary
This prediction is currently being closed. The prediction for Value Management+research disappoints with a performance of -20.37%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Value Management+research | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
Comments by krebskrebs for this prediction
In the thread Value Management+research diskutieren
Buy mit Kursziel 2,0
In the thread Trading Value Management+research
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

